• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Novo Nordisk A/S Common Stock (NY:NVO)

    59.32 UNCHANGED
    Streaming Delayed Price Updated: 7:00 PM EST, Jan 21, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 102,305
    Open 59.32
    Bid (Size) 60.43 (300)
    Ask (Size) 60.44 (100)
    Prev. Close 59.32
    Today's Range 59.32 - 59.32
    52wk Range 43.08 - 93.80
    Shares Outstanding N/A
    Dividend Yield 1.97%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Arctic Ultimatum: Trump’s Greenland Tariff Threat Triggers $4,700 Gold Surge and 870-Point Dow Plunge
    The global financial landscape was thrown into chaos on January 20, 2026, as President Donald Trump intensified his administration’s pursuit of Greenland, issuing a sweeping tariff ultimatum against... 
    Via MarketMinute
    Topics Economy Government Stocks
    News headline image
    2 Top Stocks to Double Up On Right Now ↗
    When you find winning stocks, stick with them. 
    Via The Motley Fool
    Topics Artificial Intelligence

    Performance

    YTD
    +13.2%
    +13.2%
    1 Month
    +23.3%
    +23.3%
    3 Month
    +11.1%
    +11.1%
    6 Month
    -15.3%
    -15.3%
    1 Year
    -26.8%
    -26.8%

    More News

    Read More
    News headline image
    Novo Nordisk Inks Deal With Canada’s Aspect Biosystems To Find More Diabetes Meds Besides Ozempic ↗
    Via Stocktwits
    Novo Nordisk A/S-Spons ADR (NYSE:NVO) Demonstrates a Strong Dividend Profile Backed by High Profitability ↗
    Via Chartmill
    NVO Shares Rise On Strong Kickstart For Wegovy Pill In US: Retail Eyes Up To $110 As ‘Fair Value’ ↗
    Via Stocktwits
    AbbVie Seeks To Grow Obesity Drug Portfolio — Retail Touts Drugmaker As Big Competition To Lilly ↗
    Via Stocktwits
    VKTX, TERN, GPCR Shares Rally As Novo Nordisk Sounds Willingness Towards Portfolio-Expansion Deals ↗
    Via Stocktwits
    News headline image
    What Happened to Viking Therapeutics in 2025, And Is it a Buy for 2026? ↗
    Via The Motley Fool
    News headline image
    Is Oral Wegovy a Game Changer for Novo Nordisk? ↗
    Via The Motley Fool
    News headline image
    Arctic Chill: Global Markets Reeling as Trump Demands Greenland Purchase with Massive Tariff Threats
    Via MarketMinute
    Topics Economy Government Stocks
    News headline image
    The Arctic Gambit: Trump’s National Security Push for Greenland Sparks Diplomatic Crisis and Market Volatility
    Via MarketMinute
    Topics Economy Electric Vehicles Government
    News headline image
    The Battle for the White Coat: OpenAI and Anthropic Reveal Dueling Healthcare Strategies
    Via TokenRing AI
    Topics Artificial Intelligence
    News headline image
    Ozempic, Mounjaro, Wegovy, or Zepbound? This ETF Holds Them All ↗
    Via MarketBeat
    Topics ETFs
    News headline image
    Anthropic’s New Specialized Healthcare Tiers: A New Era for AI-Driven Diagnostics and Medical Triage
    Via TokenRing AI
    Topics Artificial Intelligence
    News headline image
    The Trillion-Dollar Pharmacopeia: Eli Lilly’s (LLY) Dominance in the Age of Incretins
    Via Finterra
    Topics Economy
    News headline image
    The New Era of Johnson & Johnson: A 2026 Deep-Dive Research Feature
    Via Finterra
    Topics Artificial Intelligence Bankruptcy Economy
    News headline image
    Prediction: 2026 Will Be the Year of Eli Lilly ↗
    Via The Motley Fool
    News headline image
    The Arctic Ultimatums: Trump’s Greenland Bid Sparks Global Trade War and NATO Crisis
    Via MarketMinute
    Topics Economy Government World Trade
    News headline image
    Eli Lilly vs. Novo Nordisk: Which Is the Better Stock Buy? ↗
    Via The Motley Fool
    News headline image
    NVO Stock Is Rising Pre-Market – What Is The Wegovy News Driving Novo Nordisk Shares? ↗
    Via Stocktwits
    News headline image
    Novo Nordisk Stock Dips As Company Faces GLP-1 Antitrust Lawsuit ↗
    Via Benzinga
    Topics Lawsuit
    News headline image
    Eli Lilly’s $1.2 Billion Acquisition of Ventyx Biosciences: Bridging the Gap Between Weight Loss and Chronic Inflammation
    Via MarketMinute
    Topics Intellectual Property
    News headline image
    Eli Lilly Stock Slips After Antitrust Lawsuit Against GLP-1 Providers ↗
    Via Benzinga
    Topics Lawsuit
    Slimmer Waistlines, Fatter Margins: Jefferies Says Airline Companies Will Profit From America’s Weight-Loss Boom ↗
    Via Stocktwits
    News headline image
    Healthcare Sector Stages Resilient Rebound as Policy Clarity and GLP-1 Innovations Fuel Investor Optimism
    Via MarketMinute
    Topics Earnings Economy

    Frequently Asked Questions

    Is Novo Nordisk A/S Common Stock publicly traded?
    Yes, Novo Nordisk A/S Common Stock is publicly traded.
    What exchange does Novo Nordisk A/S Common Stock trade on?
    Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
    What is the ticker symbol for Novo Nordisk A/S Common Stock?
    The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
    What is the current price of Novo Nordisk A/S Common Stock?
    The current price of Novo Nordisk A/S Common Stock is 59.32
    When was Novo Nordisk A/S Common Stock last traded?
    The last trade of Novo Nordisk A/S Common Stock was at 01/21/26 07:00 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.